Locations:

Research

September 27, 2017/Cancer/Research

Targeted Therapies + SRS Combo Prolongs Survival in Patients with Renal Cell Carcinoma Brain Metastases

But the combination increases toxicity risks

September 27, 2017/Cancer/Research

A Pan-Cancer Encyclopedia of Genetic Variants Causing Radiation Resistance

ASTRO 2017 abstract finds radiosensitivity variants

September 27, 2017/Cancer/Research

Beyond Pack-Years: Assessing & Treating HPV+ Oropharynx Cancer

20 pack-years better indicator of high-risk disease

September 26, 2017/Cancer/Research

Analysis of Treatment Plans Suggests Guidelines Impractical for Planning with IG-VMAT for Oropharynx Cancer

Opportunity for more nuanced approach

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

September 25, 2017/Cancer/Research

Novel, Targeted Therapies for Patients with Advanced, RET-Positive NSCLC

Lenvatinib promising, trials ongoing

September 24, 2017/Cancer/Research

Single Fraction SBRT Appropriate for Long-Term Use in Inoperable Early Stage NSCLC

Data confirm original clinical trial results

September 20, 2017/Cancer/Research

When Concurrent Chemoradiotherapy Makes Sense for Older Patients

Postsurgery chemo for certain head and neck cancers

August 14, 2017/Cancer/Research

Ki67 Protein Levels Predict Which Breast Cancer Patients Respond to Endocrine Therapy

A recent clinical trial tested neoadjuvant therapies

August 4, 2017/Cancer/Research

Neratinib FDA Approval for Extended Adjuvant Therapy a Win for HER2+ Patients

Safe, effective, welcome option

July 5, 2017/Cancer/Research

Circulating Cell-Free Genome Atlas Study Aims to Detect Cancer Before Symptoms Occur

Deep sequencing may help map cancer genetics

BackPage 27 of 31Next